Fabrizio Benedetti Selected Research

Opioid Analgesics (Opioids)

8/2020	Understanding the mechanisms of placebo and nocebo effects.
3/2013	Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems.
10/2011	Placebo analgesia and beyond: a melting pot of concepts and ideas for neuroscience.
5/2011	Ask the Experts: Is there a place for placebo analgesia in everyday clinical practice?
10/2007	Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions?
3/2003	Placebo analgesia and the heart.
2/2001	Response variability to analgesics: a role for non-specific activation of endogenous opioids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizio Benedetti Research Topics

Disease

38	Pain (Aches) 10/2023 - 02/2001
10	Parkinson Disease (Parkinson's Disease) 10/2023 - 01/2003
10	Hyperalgesia 01/2023 - 05/2003
7	Neoplasms (Cancer) 04/2024 - 01/2021
7	Headache (Headaches) 10/2022 - 05/2014
4	Fatigue 04/2020 - 07/2008
4	Hypoxia (Hypoxemia) 01/2020 - 05/2014
4	Neuralgia (Stump Neuralgia) 01/2018 - 06/2012
3	Cough 10/2022 - 10/2013
2	Migraine Disorders (Migraine) 10/2023 - 12/2009
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 12/2021
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 11/2021
2	Chest Pain (Chest Pains) 10/2022 - 11/2021
2	Movement Disorders (Movement Disorder) 01/2018 - 07/2008
2	Chronic Pain 12/2014 - 06/2012
2	Cognitive Dysfunction 05/2012 - 12/2010
2	Alzheimer Disease (Alzheimer's Disease) 05/2012 - 03/2006
1	Melanoma (Melanoma, Malignant) 02/2024
1	Skin Diseases (Skin Disease) 10/2023
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2023
1	Dementia (Dementias) 10/2023
1	Obesity 10/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2023
1	Human Influenza (Influenza) 10/2023
1	Intellectual Disability (Idiocy) 10/2023
1	Sleep Wake Disorders 10/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Low Back Pain (Lumbago) 05/2019
1	Necrosis 01/2019
1	Rheumatic Diseases (Rheumatism) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Hypokinesia (Bradykinesia) 10/2017
1	Motor Disorders 10/2016
1	Pathologic Processes 02/2015
1	Alkalosis 01/2015

Drug/Important Bio-Agent (IBA)

12	PlacebosIBA 01/2018 - 09/2004
7	Opioid Analgesics (Opioids)IBA 08/2020 - 02/2001
6	Analgesics (Analgesic Drugs)IBA 01/2021 - 02/2001
6	Cholecystokinin (Pancreozymin)IBA 08/2020 - 11/2006
5	Oxygen (Dioxygen)IBA 10/2022 - 01/2015
4	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2016
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2020 - 05/2014
4	ProstaglandinsIBA 01/2018 - 05/2014
3	Naloxone (Narcan)FDA LinkGeneric 01/2023 - 02/2001
3	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 11/2006
3	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 06/2012
3	Narcotic Antagonists (Opioid Antagonists)IBA 03/2013 - 02/2001
2	VaccinesIBA 10/2023 - 10/2023
2	AntigensIBA 01/2023 - 12/2021
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 11/2021 - 11/2015
2	Biosimilar PharmaceuticalsIBA 01/2021 - 01/2019
2	CannabinoidsIBA 08/2020 - 03/2013
2	Caffeine (No Doz)FDA LinkGeneric 04/2020 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 12/2014
2	ThromboxanesIBA 01/2015 - 05/2014
2	Morphine (MS Contin)FDA LinkGeneric 02/2011 - 10/2007
1	Interleukin-2 (IL2)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	EpitopesIBA 10/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Viral AntigensIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	CD40 Ligand (CD40L)IBA 12/2021
1	Dimethindene (Dimetindene)IBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Adalimumab (Humira)FDA Link 01/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 10/2018
1	SynucleinsIBA 10/2018
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2018
1	Haloperidol (Haldol)FDA LinkGeneric 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2018
1	Apomorphine FDA Link 10/2017
1	Prostaglandins EIBA 11/2015
1	DinoprostIBA 01/2015
1	Prostaglandin D2IBA 01/2015
1	Dinoprostone (PGE2)FDA Link 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2014
1	Laminin (Merosin)IBA 12/2014

Therapy/Procedure

16	Analgesia 11/2021 - 03/2003
3	Immunotherapy 04/2024 - 01/2022
3	Therapeutics 02/2024 - 01/2003
3	Tourniquets 10/2023 - 02/2011
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2024 - 02/2024
2	Radiotherapy 01/2022 - 01/2021
2	Deep Brain Stimulation 01/2021 - 01/2003
2	Pain Management 03/2013 - 12/2010
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2021
1	Transcranial Direct Current Stimulation 11/2021
1	Drug Tapering 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Denervation 05/2019
1	Injections 05/2019
1	Neurological Rehabilitation 01/2018